Premarin (Conjugated Estrogens) - Adverse Event Reports - Hospitalization - Cerebrovascular Accident

Adverse event in 60 year old female receiving Premarin (Conjugated Estrogens)

Reported by a individual with unspecified qualification from United States on 2007-10-30

Patient: 60 year old female, weighing 70.4 kg (154.8 pounds)

Adverse reactions / side effects: Pulmonary Embolism, Cerebrovascular Accident

Adverse event resulted in: hospitalization

Suspect drug(s):
Cycrin
    Dosage: oral
    Administration route: Oral
    Start date: 1989-07-01
    End date: 1999-07-01

Premarin
    Dosage: oral
    Administration route: Oral
    Start date: 1989-07-01
    End date: 1999-07-01

Provera

Adverse event in female receiving Premarin (Conjugated Estrogens)

Reported by a physician from United States on 2007-10-30

Patient: female, weighing 55.8 kg (122.8 pounds)

Adverse reactions / side effects: Cerebrovascular Accident

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Premarin (Conjugated Estrogens)

Adverse event in 60 year old female receiving Premarin (Conjugated Estrogens)

Reported by a individual with unspecified qualification from United States on 2007-10-30

Patient: 60 year old female, weighing 70.4 kg (154.8 pounds)

Adverse reactions / side effects: Pulmonary Embolism, Cerebrovascular Accident

Adverse event resulted in: hospitalization

Suspect drug(s):
Cycrin
    Dosage: unspecified, oral
    Administration route: Oral
    Start date: 1989-07-01
    End date: 1999-07-01

Premarin
    Dosage: unspecified, oral
    Administration route: Oral
    Start date: 1999-07-01
    End date: 1999-07-01

Provera

Adverse event in female receiving Premarin (Conjugated Estrogens)

Reported by a physician from United States on 2007-10-30

Patient: female

Adverse reactions / side effects: Thrombosis, Cerebrovascular Accident

Adverse event resulted in: hospitalization

Suspect drug(s):
Premarin (Conjugated Estrogens)

Adverse event in female receiving Premarin (Conjugated Estrogens)

Reported by a consumer/non-health professional from United States on 2007-10-26

Patient: female, weighing 66.7 kg (146.8 pounds)

Adverse reactions / side effects: Embolic Stroke, Intracranial Aneurysm, Aneurysm, Cerebrovascular Accident, Migraine With Aura

Adverse event resulted in: hospitalization

Suspect drug(s):
MPA

Premarin

Prempro
    Dosage: unspecified dose daily
    Administration route: Oral
    Indication: Hormone Replacement Therapy
    Start date: 2000-03-01
    End date: 2001-02-01

Adverse event in 72 year old female receiving Premarin (Conjugated Estrogens)

Reported by a individual with unspecified qualification from United States on 2007-07-17

Patient: 72 year old female, weighing 93.0 kg (204.5 pounds)

Adverse reactions / side effects: Diabetes Mellitus, Pyrexia, Cerebrovascular Disorder, Chronic Obstructive Pulmonary Disease, Macular Degeneration, Cerebral Ischaemia, Colonic Polyp, Glomerulonephritis, Breast Microcalcification, Lymphadenectomy, Breast Cancer, Coronary Angioplasty, Radiotherapy, Breast Mass, Coronary Artery Disease, Tremor, Cholelithiasis, Diverticulum, Arachnoid Cyst, Nervous System Disorder, Cholecystectomy, Adenoma Benign, Spinal Column Stenosis, Refractory Anaemia, Myelodysplastic Syndrome, Dialysis, Cholecystitis, Depression, Acute Myocardial Infarction, Endometrial Disorder, Macrocytosis, Gouty Arthritis, Peripheral Vascular Disorder, Malignant Breast Lump Removal, Cerebrovascular Accident, Renal Failure Chronic, Vascular Graft, Hyperlipidaemia, Anxiety, Osteoarthritis, Peritoneal Dialysis, Hypothyroidism, Hypertension, Infection

Adverse event resulted in: hospitalization

Suspect drug(s):
Cycrin
    Dosage: 5 mg, unk
    Administration route: Oral
    Indication: Menopause
    Start date: 1999-01-01
    End date: 1999-01-01

Estraderm
    Dosage: 0.5 mg, unk
    Indication: Menopause
    Start date: 1991-01-01
    End date: 1996-01-01

MPA
    Dosage: 5 mg, unk
    Administration route: Oral
    Indication: Menopause
    Start date: 1999-01-01
    End date: 2000-01-01

Premarin
    Administration route: Oral
    Indication: Menopause
    Start date: 1999-01-01
    End date: 2001-01-01

Provera
    Dosage: 2.5 mg, unk
    Administration route: Oral
    Indication: Menopause
    Start date: 1991-01-01
    End date: 1999-01-01

Other drugs received by patient: Celexa; Zestril; Metoprolol Succinate; Lortab; Lipitor; Allopurinol; Synthroid; Ranitidine; Nitroglycerin; Nortriptyline HCL; Norvasc; Cardizem; Capoten; Mevacor; Voltaren; Zaroxolyn

Adverse event in 47 year old female receiving Premarin (Conjugated Estrogens)

Reported by a health professional (non-physician/pharmacist) from South Africa on 2007-05-24

Patient: 47 year old female

Adverse reactions / side effects: Chest Pain, Cerebrovascular Accident

Adverse event resulted in: hospitalization

Suspect drug(s):
Premarin (Conjugated Estrogens)

Other drugs received by patient: Provera

Adverse event in female receiving Premarin (Conjugated Estrogens)

Reported by a consumer/non-health professional from United States on 2007-05-03

Patient: female, weighing 55.4 kg (121.9 pounds)

Adverse reactions / side effects: Hemiparesis, Hypoaesthesia, Cerebrovascular Accident, Paraesthesia

Adverse event resulted in: hospitalization

Suspect drug(s):
Medroxyprogesterone Acetate
    Dosage: unspecified
    Administration route: Oral
    Indication: Hormone Replacement Therapy
    Start date: 1980-01-01
    End date: 1999-04-06

Premarin
    Dosage: unspecified dosage
    Administration route: Oral
    Indication: Hormone Replacement Therapy
    Start date: 1980-01-01
    End date: 1999-04-06

Prempro
    Dosage: unknown
    Administration route: Oral
    Indication: Hormone Replacement Therapy
    Start date: 1999-04-06
    End date: 2003-10-01

Adverse event in 57 year old female receiving Premarin (Conjugated Estrogens)

Reported by a individual with unspecified qualification from United States on 2007-04-10

Patient: 57 year old female, weighing 62.1 kg (136.7 pounds)

Adverse reactions / side effects: Dizziness Postural, Visual Acuity Reduced, Headache, Tricuspid Valve Incompetence, Cardiac Septal Defect, Malaise, Hot Flush, Balance Disorder, Vulvovaginal Dryness, Hemianopia Homonymous, Mitral Valve Prolapse, Visual Field Defect, Ovarian Cyst, Osteopenia, Temporomandibular Joint Syndrome, Cerebral Infarction, Dehydration, Carotid Artery Disease, Osteoporosis, Gastrointestinal Inflammation, Fall, Abdominal Pain Upper, Reflux Oesophagitis, Lethargy, Nausea, Muscular Weakness, Musculoskeletal Chest Pain, Amnesia, Cerebrovascular Accident, Dysarthria, Hyperlipidaemia, Fibromuscular Dysplasia, Flank Pain, Mitral Valve Incompetence, Ejection Fraction Decreased, Vertigo, Vulval Leukoplakia, Gait Disturbance, Asthenia

Adverse event resulted in: hospitalization

Suspect drug(s):
Cycrin
    Dosage: 2.5 mg, unk
    Indication: Hormone Replacement Therapy

Estraderm
    Indication: Hormone Replacement Therapy

Estring
    Dosage: 2 mg, unk
    Indication: Hormone Replacement Therapy

Medroxyprogesterone Acetate
    Dosage: 10 mg, unk
    Indication: Hormone Replacement Therapy

Premarin
    Indication: Hormone Replacement Therapy

Other drugs received by patient: Zantac; Prilosec; Zocor; Lipitor; Metoclopramide

Adverse event in 62 year old female receiving Premarin (Conjugated Estrogens)

Reported by a individual with unspecified qualification from United States on 2007-03-30

Patient: 62 year old female, weighing 76.6 kg (168.6 pounds)

Adverse reactions / side effects: Tricuspid Valve Incompetence, Headache, Chronic Obstructive Pulmonary Disease, Cardiomegaly, Hyperventilation, Breast Cyst, Palpitations, Mood Altered, Biliary Dilatation, Arteriosclerosis, Ventricular Extrasystoles, Back Pain, Inner Ear Disorder, Breast Mass, Diverticulum Intestinal, Mitral Valve Calcification, Breast Cancer Metastatic, Uterine Haemorrhage, Salpingo-Oophorectomy Bilateral, Pain, Aortic Valve Sclerosis, Effusion, Ventricular Hypertrophy, Fibrocystic Breast Disease, Chest Pain, Intervertebral Disc Degeneration, Chronic Sinusitis, Cerebral Arteriosclerosis, Breast Disorder, Cerebral Atrophy, Vulvar Dysplasia, Cerebrovascular Accident, Tubal Ligation, Hysterectomy, Osteoarthritis, Panic Attack, Radical Mastectomy, Mitral Valve Incompetence, Ejection Fraction Decreased, Vertigo, Spinal Osteoarthritis, Ischaemic Cerebral Infarction

Adverse event resulted in: hospitalization

Suspect drug(s):
Combipatch
    Indication: Hormone Replacement Therapy
    Start date: 1988-01-01
    End date: 1996-01-01

Estraderm
    Indication: Hormone Replacement Therapy
    Start date: 1988-01-01
    End date: 1996-01-01

Premarin
    Indication: Hormone Replacement Therapy
    Start date: 1988-01-01
    End date: 1996-01-01

Prempro
    Dosage: .625/2.5 mg
    Indication: Hormone Replacement Therapy
    Start date: 1970-01-01
    End date: 1998-02-01

Provera
    Dosage: 2.5 mg, qd
    Administration route: Oral
    Indication: Hormone Replacement Therapy
    Start date: 1996-01-01
    End date: 1998-02-01

Other drugs received by patient: Mestinon; Neostigmine Bromide; Ephedrine SUL CAP

Adverse event in 51 year old female receiving Premarin (Conjugated Estrogens)

Reported by a individual with unspecified qualification from United States on 2007-03-27

Patient: 51 year old female

Adverse reactions / side effects: Asthma, Facial Palsy, Thrombosis, Lymphadenopathy, Hypoglycaemia, Cerebrovascular Disorder, Lipids Increased, Peripheral Sensory Neuropathy, Uterine Leiomyoma, Irritable Bowel Syndrome, Hypoxia, Postmenopausal Haemorrhage, Breast Cancer, Pneumonia, Pain in Extremity, Breast Mass, Hypoaesthesia, Diverticulum Intestinal, Adenomyosis, Gastric Bypass, Diabetic Neuropathy, Nervous System Disorder, Gastric Polyps, Sleep Apnoea Syndrome, Uterine Haemorrhage, Aphasia, Neuropathy Peripheral, Fibrocystic Breast Disease, Fibromyalgia, Obesity, Depression, Transient Ischaemic Attack, Lymphoedema, Abdominal Pain Lower, Migraine, Motor Dysfunction, Cognitive Disorder, Hysterosalpingo-Oophorectomy, Amnesia, Diabetes Mellitus non-Insulin-Dependent, Cerebrovascular Accident, Anxiety, Dysarthria, Osteoarthritis, Diarrhoea, Arthralgia, Radical Mastectomy, Mastectomy, Gait Disturbance, Hypertension

Adverse event resulted in: hospitalization

Suspect drug(s):
Estraderm
    Dosage: 0.1 mg, unk
    Indication: Hormone Replacement Therapy
    Start date: 1997-08-01
    End date: 2000-02-01

Estraderm
    Dosage: 0.5 mg, unk
    Start date: 1994-04-01
    End date: 1997-06-01

MPA
    Dosage: 2.5 mg, unk
    Administration route: Oral
    Indication: Hormone Replacement Therapy
    Start date: 1994-09-01
    End date: 2000-02-16

Premarin
    Indication: Hormone Replacement Therapy

Provera
    Dosage: 2.5 mg, unk
    Administration route: Oral
    Indication: Hormone Replacement Therapy
    Start date: 1994-03-01
    End date: 1994-08-01

Vivelle
    Dosage: 0.1 mg, unk
    Indication: Hormone Replacement Therapy
    Start date: 1997-10-01
    End date: 1997-12-01

Adverse event in female receiving Premarin (Conjugated Estrogens)

Reported by a lawyer from United States on 2007-03-20

Patient: female

Adverse reactions / side effects: Breast Cancer, Diabetes Mellitus, Pancreatitis, Cerebrovascular Accident

Adverse event resulted in: hospitalization

Suspect drug(s):
0.1mg Levonorgestrel / 0.02mg Ethinyl Estradiol / Inert

Depo-Provera

Estratest

Medroxyprogesterone Acetate

Medroxyprogesterone Acetate
    Indication: Hormone Replacement Therapy

Premarin

Prempro

Other drugs received by patient: Glucophage; Lopid; Pravachol; Ativan; Ascorbic Acid; Vitamin B Complex CAP; Synthroid

Adverse event in 58 year old female receiving Premarin (Conjugated Estrogens)

Reported by a physician from United States on 2007-03-15

Patient: 58 year old female

Adverse reactions / side effects: Pulmonary Hypertension, Biopsy Breast Abnormal, Diabetes Mellitus, Dilatation Ventricular, Tricuspid Valve Incompetence, Treatment Noncompliance, Surgery, Atrial Hypertrophy, Oedema Peripheral, Breast Hyperplasia, Echocardiogram, Back Pain, Supraventricular Tachycardia, Breast Cancer Female, Cholelithiasis, Ventricular Dysfunction, Cholecystectomy, Homicidal Ideation, Scan Myocardial Perfusion Abnormal, Head Injury, Breast Cancer Stage IV, Pain, Hemiparesis, Fall, Fatigue, Fibrocystic Breast Disease, Coronary Artery Bypass, Dizziness, Lymphoedema, Atrial Flutter, Urinary Tract Infection, Atrial Fibrillation, Cerebrovascular Accident, Cardiac Pacemaker Insertion, Arthralgia, Mitral Valve Incompetence, Infarction

Adverse event resulted in: hospitalization

Suspect drug(s):
Curretab
    Indication: Hormone Replacement Therapy
    Start date: 1985-01-01
    End date: 1995-01-01

Cycrin
    Indication: Hormone Replacement Therapy
    Start date: 1985-01-01
    End date: 1995-01-01

Estrace
    Indication: Hormone Replacement Therapy
    Start date: 1985-01-01
    End date: 1995-01-01

Estratest
    Indication: Hormone Replacement Therapy
    Start date: 1985-01-01
    End date: 1995-01-01

MPA
    Indication: Hormone Replacement Therapy
    Start date: 1985-01-01
    End date: 1995-01-01

Premarin
    Dosage: 10 mg, unk
    Administration route: Oral
    End date: 1996-08-01

Prempro
    Dosage: 0.625/25 mg, unk
    Indication: Hormone Replacement Therapy
    Start date: 1996-08-01
    End date: 2002-08-01

Provera
    Dosage: 0.625 mg, unk
    Administration route: Oral
    End date: 1996-08-01

Vivelle
    Indication: Hormone Replacement Therapy
    Start date: 1985-01-01
    End date: 1995-01-01

Adverse event in 53 year old female receiving Premarin (Conjugated Estrogens)

Reported by a consumer/non-health professional from United States on 2007-02-23

Patient: 53 year old female, weighing 90.7 kg (199.5 pounds)

Adverse reactions / side effects: Progesterone Receptor Assay Positive, Hepatitis, Cerebrovascular Accident, Breast Cancer Metastatic, Respiratory Failure, Oestrogen Receptor Assay Positive, Deep Vein Thrombosis, Renal Failure Acute

Adverse event resulted in: death, hospitalization

Suspect drug(s):
Climara
    Dosage: .05 mg/d, cont
    Indication: Menopause
    Start date: 1998-01-01
    End date: 1998-01-01

Medroxyprogesterone
    Dosage: 2.5 mg, unk
    Indication: Menopause
    Start date: 1998-01-01
    End date: 2000-01-01

Premarin
    Dosage: 1.25 mg, unk
    Indication: Menopause
    Start date: 1998-01-01
    End date: 1999-01-01

Prempro
    Dosage: 0.625/2.5 mg, unk
    Indication: Menopause
    Start date: 1997-01-01
    End date: 1997-01-01

Provera
    Dosage: 2.5 mg, unk
    Indication: Menopause
    Start date: 1998-01-01
    End date: 1998-01-01

Other drugs received by patient: Kerlone; Xanax

Adverse event in female receiving Premarin (Conjugated Estrogens)

Reported by a health professional (non-physician/pharmacist) from United States on 2007-02-09

Patient: female

Adverse reactions / side effects: Breast Cancer Metastatic, Cerebrovascular Accident

Adverse event resulted in: hospitalization

Suspect drug(s):
Cycrin

Premarin
    Indication: Hormone Replacement Therapy

Prempro
    Indication: Hormone Replacement Therapy

Provera
    Indication: Hormone Replacement Therapy